|Videos|August 19, 2022
The Changing Landscape of Digital Trials
Author(s)Veeva Systems
Richard Young, Vice President of Strategy, Vault CDMS and Tim Davis, Vice President of Strategy, MyVeeva for Patients, discuss the future of digital trials and their impact in the industry.
Advertisement
- It is important to not get caught up on the terminology involved in the new landscape for clinical trials; digital is the how while decentralized is where a trial is done.
- The patient experience within digital trials can be improved by streamlining information and access into a single application.
- Veeva takes an end-to-end approach with clinical trials so patients can participate in them, while taking into consideration their routines and lifestyles.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
